EMA — authorised 15 September 2016
- Marketing authorisation holder: Techdow Pharma Netherlands B.V.
- Status: approved
EMA authorised Lovenox (Preservative Free) on 15 September 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 15 September 2016.
Techdow Pharma Netherlands B.V. holds the EU marketing authorisation.